WebMay 20, 2010 · Journal of Clinical Oncology: Vol 28, No 15 Vol. 28, No. 15, May 20, 2010 EDITORIAL Improving Prostate-Specific Antigen Screening Strope et al. pp. 2491–2492 Citation Full Text PDF (55 KB) ORIGINAL REPORTS Genitourinary Cancer Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An … WebSep 10, 2010 · PMCID: PMC4872327 DOI: 10.1200/JCO.2010.27.9992 Abstract Histopathologic examination reveals that most human tumors are associated with diverse immune cell infiltrates, but the roles of host reactions in disease pathogenesis and prognosis remain to be fully clarified.
原发性中枢神经系统淋巴瘤的治疗现状与进展
WebAbstract: In the last decades, ... J Clin Oncol. 2010;28(10):1684–1691. 10. Dai X, Li T, Bai Z, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. ... J Clin Oncol. 2004;22(19):4010–4018. 15. Khatcheressian JL, Wolff AC, Smith TJ, et al. American society of clinical oncology 2006 update of the breast ... http://asco.org/ har traces azure
Electron Radiotherapy: Past, Present, and Future John …
http://xuebao.sdfmu.edu.cn/CN/10.3969/j.issn.2097-0005.2024.02.002 WebApr 14, 2024 · Abstract. Castration-resistant prostate cancer (CRPC), especially metastatic castration-resistant prostate cancer (mCRPC) is one of the most prevalent malignancies and main cause of cancer-related death among men in the world. ... J Clin Oncol, 37 (2024), pp. 1051-1061. CrossRef View in Scopus Google Scholar. ... N Engl J Med, 363 (2010), pp ... WebApr 14, 2024 · DOI: 10.1200/JCO.22.00193 Journal of Clinical Oncology - published online before print April 14, 2024 PMID: 35420921 Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer Andrew J. Armstrong , MD, ScM1 ; Arun A. Azad , MBBS, PhD2,3 ; Taro Iguchi , MD, PhD4 ; Russell Z. Szmulewitz, MD5 har trace safari